Addition of Molecular Adsorbent Recirculating System (MARS®) Albumin Dialysis for the Preoperative Management of Jaundiced Patients with Hilar Cholangiocarcinoma

The preoperative management of hilar cholangiocarcinoma (HC) with jaundice focuses on decreasing the total serum bilirubin level (SBL) by performing preoperative biliary drainage (PBD). However, it takes about 6-8 weeks for the SBL to fall at a sufficient extent. The objective of this preliminary st...

Full description

Bibliographic Details
Main Authors: Jean-Marc Regimbeau, David Fuks, Emilie Chapuis-Roux, Thierry Yzet, Cyril Cosse, Eric Bartoli, Eric N'Guyen-Khac, Brice Robert, Eric Lobjoie
Format: Article
Language:English
Published: Karger Publishers 2013-09-01
Series:Case Reports in Gastroenterology
Subjects:
Online Access:http://www.karger.com/Article/FullText/355343
id doaj-043163ed494b4cb6b9d23e04b592af44
record_format Article
spelling doaj-043163ed494b4cb6b9d23e04b592af442020-11-24T22:29:17ZengKarger PublishersCase Reports in Gastroenterology1662-06312013-09-017339640310.1159/000355343355343Addition of Molecular Adsorbent Recirculating System (MARS®) Albumin Dialysis for the Preoperative Management of Jaundiced Patients with Hilar CholangiocarcinomaJean-Marc RegimbeauDavid FuksEmilie Chapuis-RouxThierry YzetCyril CosseEric BartoliEric N'Guyen-KhacBrice RobertEric LobjoieThe preoperative management of hilar cholangiocarcinoma (HC) with jaundice focuses on decreasing the total serum bilirubin level (SBL) by performing preoperative biliary drainage (PBD). However, it takes about 6-8 weeks for the SBL to fall at a sufficient extent. The objective of this preliminary study was to evaluate the impact of Molecular Adsorbent Recirculating System (MARS®) dialysis (in association with PBD) on SBL decrease. From January 2010 to January 2011, we prospectively selected all jaundiced patients admitted to our university hospital for resectable HC and requiring PBD prior to major hepatectomy. The PBD was followed by 3 sessions of MARS dialysis over a period of 72 h. A total of 10 patients with HC were screened and two of them were included (Bismuth-Corlette stage IIIa, gender ratio 1, median age 68 years). The initial SBL in the two patients was 328 and 242 μmol/l, respectively. After three MARS dialysis sessions, the SBL had fallen by 30 and 52%, respectively. After the end of each session, there was a SBL rebound of about 10 μmol/l. The MARS decreased the serum creatinine level, the platelet count and the prothrombin index, but did not modify the serum albumin level. Pruritus disappeared after one and two sessions, respectively. MARS-related morbidity included hypotension (n = 1), tachycardia (n = 1), thrombocytopenia (n = 2) and anaemia (n = 1). When combined with PBD, MARS dialysis appears to accelerate the decrease in SBL and thus may enable earlier surgery. This hypothesis must be validated in a larger study.http://www.karger.com/Article/FullText/355343Hilar cholangiocarcinomaAlbumin dialysisMARS®Serum bilirubin level
collection DOAJ
language English
format Article
sources DOAJ
author Jean-Marc Regimbeau
David Fuks
Emilie Chapuis-Roux
Thierry Yzet
Cyril Cosse
Eric Bartoli
Eric N'Guyen-Khac
Brice Robert
Eric Lobjoie
spellingShingle Jean-Marc Regimbeau
David Fuks
Emilie Chapuis-Roux
Thierry Yzet
Cyril Cosse
Eric Bartoli
Eric N'Guyen-Khac
Brice Robert
Eric Lobjoie
Addition of Molecular Adsorbent Recirculating System (MARS®) Albumin Dialysis for the Preoperative Management of Jaundiced Patients with Hilar Cholangiocarcinoma
Case Reports in Gastroenterology
Hilar cholangiocarcinoma
Albumin dialysis
MARS®
Serum bilirubin level
author_facet Jean-Marc Regimbeau
David Fuks
Emilie Chapuis-Roux
Thierry Yzet
Cyril Cosse
Eric Bartoli
Eric N'Guyen-Khac
Brice Robert
Eric Lobjoie
author_sort Jean-Marc Regimbeau
title Addition of Molecular Adsorbent Recirculating System (MARS®) Albumin Dialysis for the Preoperative Management of Jaundiced Patients with Hilar Cholangiocarcinoma
title_short Addition of Molecular Adsorbent Recirculating System (MARS®) Albumin Dialysis for the Preoperative Management of Jaundiced Patients with Hilar Cholangiocarcinoma
title_full Addition of Molecular Adsorbent Recirculating System (MARS®) Albumin Dialysis for the Preoperative Management of Jaundiced Patients with Hilar Cholangiocarcinoma
title_fullStr Addition of Molecular Adsorbent Recirculating System (MARS®) Albumin Dialysis for the Preoperative Management of Jaundiced Patients with Hilar Cholangiocarcinoma
title_full_unstemmed Addition of Molecular Adsorbent Recirculating System (MARS®) Albumin Dialysis for the Preoperative Management of Jaundiced Patients with Hilar Cholangiocarcinoma
title_sort addition of molecular adsorbent recirculating system (mars®) albumin dialysis for the preoperative management of jaundiced patients with hilar cholangiocarcinoma
publisher Karger Publishers
series Case Reports in Gastroenterology
issn 1662-0631
publishDate 2013-09-01
description The preoperative management of hilar cholangiocarcinoma (HC) with jaundice focuses on decreasing the total serum bilirubin level (SBL) by performing preoperative biliary drainage (PBD). However, it takes about 6-8 weeks for the SBL to fall at a sufficient extent. The objective of this preliminary study was to evaluate the impact of Molecular Adsorbent Recirculating System (MARS®) dialysis (in association with PBD) on SBL decrease. From January 2010 to January 2011, we prospectively selected all jaundiced patients admitted to our university hospital for resectable HC and requiring PBD prior to major hepatectomy. The PBD was followed by 3 sessions of MARS dialysis over a period of 72 h. A total of 10 patients with HC were screened and two of them were included (Bismuth-Corlette stage IIIa, gender ratio 1, median age 68 years). The initial SBL in the two patients was 328 and 242 μmol/l, respectively. After three MARS dialysis sessions, the SBL had fallen by 30 and 52%, respectively. After the end of each session, there was a SBL rebound of about 10 μmol/l. The MARS decreased the serum creatinine level, the platelet count and the prothrombin index, but did not modify the serum albumin level. Pruritus disappeared after one and two sessions, respectively. MARS-related morbidity included hypotension (n = 1), tachycardia (n = 1), thrombocytopenia (n = 2) and anaemia (n = 1). When combined with PBD, MARS dialysis appears to accelerate the decrease in SBL and thus may enable earlier surgery. This hypothesis must be validated in a larger study.
topic Hilar cholangiocarcinoma
Albumin dialysis
MARS®
Serum bilirubin level
url http://www.karger.com/Article/FullText/355343
work_keys_str_mv AT jeanmarcregimbeau additionofmolecularadsorbentrecirculatingsystemmarsalbumindialysisforthepreoperativemanagementofjaundicedpatientswithhilarcholangiocarcinoma
AT davidfuks additionofmolecularadsorbentrecirculatingsystemmarsalbumindialysisforthepreoperativemanagementofjaundicedpatientswithhilarcholangiocarcinoma
AT emiliechapuisroux additionofmolecularadsorbentrecirculatingsystemmarsalbumindialysisforthepreoperativemanagementofjaundicedpatientswithhilarcholangiocarcinoma
AT thierryyzet additionofmolecularadsorbentrecirculatingsystemmarsalbumindialysisforthepreoperativemanagementofjaundicedpatientswithhilarcholangiocarcinoma
AT cyrilcosse additionofmolecularadsorbentrecirculatingsystemmarsalbumindialysisforthepreoperativemanagementofjaundicedpatientswithhilarcholangiocarcinoma
AT ericbartoli additionofmolecularadsorbentrecirculatingsystemmarsalbumindialysisforthepreoperativemanagementofjaundicedpatientswithhilarcholangiocarcinoma
AT ericnguyenkhac additionofmolecularadsorbentrecirculatingsystemmarsalbumindialysisforthepreoperativemanagementofjaundicedpatientswithhilarcholangiocarcinoma
AT bricerobert additionofmolecularadsorbentrecirculatingsystemmarsalbumindialysisforthepreoperativemanagementofjaundicedpatientswithhilarcholangiocarcinoma
AT ericlobjoie additionofmolecularadsorbentrecirculatingsystemmarsalbumindialysisforthepreoperativemanagementofjaundicedpatientswithhilarcholangiocarcinoma
_version_ 1725744110272249856